We test computational techniques for robust cell type classification and find that T-cells in BPDCN patients consistently upregulate interferon alpha (IFNA) response and downregulate tumor necrosis factor alpha (TNFA) pathways. This evidence concerns the gene IFNA1 and CD4+/CD56+ hematodermic neoplasm.